- Home
- SBH vs NUVB Comparison
SBH vs NUVB Comparison
Compare SBH & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- NUVB
- Stock Information
- Founded
- SBH 1964
- NUVB 2018
- Country
- SBH United States
- NUVB United States
- Employees
- SBH N/A
- NUVB N/A
- Industry
- SBH Other Specialty Stores
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- NUVB Health Care
- Exchange
- SBH Nasdaq
- NUVB Nasdaq
- Market Cap
- SBH 940.7M
- NUVB 774.1M
- IPO Year
- SBH 2006
- NUVB N/A
- Fundamental
- Price
- SBH $8.94
- NUVB $2.21
- Analyst Decision
- SBH Buy
- NUVB Strong Buy
- Analyst Count
- SBH 6
- NUVB 6
- Target Price
- SBH $12.70
- NUVB $7.67
- AVG Volume (30 Days)
- SBH 2.7M
- NUVB 1.7M
- Earning Date
- SBH 02-13-2025
- NUVB 03-03-2025
- Dividend Yield
- SBH N/A
- NUVB N/A
- EPS Growth
- SBH 4.93
- NUVB N/A
- EPS
- SBH 1.66
- NUVB N/A
- Revenue
- SBH $3,723,624,000.00
- NUVB $2,162,000.00
- Revenue This Year
- SBH $0.99
- NUVB N/A
- Revenue Next Year
- SBH $1.73
- NUVB $374.06
- P/E Ratio
- SBH $5.39
- NUVB N/A
- Revenue Growth
- SBH 0.57
- NUVB N/A
- 52 Week Low
- SBH $8.88
- NUVB $1.67
- 52 Week High
- SBH $14.79
- NUVB $4.16
- Technical
- Relative Strength Index (RSI)
- SBH 29.99
- NUVB 37.58
- Support Level
- SBH $9.03
- NUVB $2.16
- Resistance Level
- SBH $9.67
- NUVB $2.38
- Average True Range (ATR)
- SBH 0.51
- NUVB 0.12
- MACD
- SBH -0.07
- NUVB 0.00
- Stochastic Oscillator
- SBH 2.91
- NUVB 16.13
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).